Evidence map›Paper›PMID 29800122›Full record

Trial reportJAMA oncology2018

Association of Low-Fat Dietary Pattern With Breast Cancer Overall Survival: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trial.

Rowan T Chlebowski, Aaron K Aragaki, Garnet L Anderson, Michael S Simon, JoAnn E Manson, Marian L Neuhouser, Kathy Pan, Marcia L Stefanic, Thomas E Rohan, Dorothy Lane and 3 more

Erratum issued Registry-linked trialOpen access · bronzeAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in JAMA oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT00000611 (Women's Health Initiative), which is not on this map. Cited by 45 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 3 pooled it
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00000611 phase3completednot on this map

Women's Health Initiative (WHI)

TypeinterventionalSponsorNational Heart, Lung, and Blood Institute (NHLBI)ConditionsBone Diseases, Breast Neoplasms, Cardiovascular Diseases, Colonic NeoplasmsArmshormone replacement therapy, estrogens, progestins, estrogen replacement therapy, diet, fat-restricted
3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 3 syntheses or guidelines pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Dietary Modification and Breast Cancer Mortality: Long-Term Follow-Up of the Women's Health Initiative Randomized Trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020
    Trial
  7. Trial
  8. Review
  9. Article
  10. Review
  11. Breast cancer: pathogenesis and treatments.Signal transduction and targeted therapy · 2025
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Dietary Fats and All-cause and Breast Cancer-specific Mortality among Women with Breast Cancer: The Western New York Exposures and Breast Cancer Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  17. Observational
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 1 country.

Rowan T ChlebowskiCity of Hope National Medical Center, Department of Medical Oncology and Therapeutics Research, Duarte, California.
Aaron K AragakiFred Hutchinson Cancer Research Center, Division of Public Health Sciences, Seattle, Washington.
Garnet L AndersonFred Hutchinson Cancer Research Center, Division of Public Health Sciences, Seattle, Washington.
Michael S SimonWayne State University, Karmanos Cancer Institute, Detroit, Michigan.
JoAnn E MansonBrigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Marian L NeuhouserFred Hutchinson Cancer Research Center, Division of Public Health Sciences, Seattle, Washington.
Kathy PanLos Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Department of Medicine, Torrance, California.
Marcia L StefanicStanford Prevention Research Center, School of Medicine, Stanford University, Palo Alto, California.
Thomas E RohanDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York.
Dorothy LaneStony Brook University, Preventive Medicine, Stony Brook, New York.
Lihong QiDepartment of Public Health Sciences, University of California at Davis.
Linda SnetselaarCollege of Public Health, University of Iowa, Iowa City/Davenport.
Ross L PrenticeFred Hutchinson Cancer Research Center, Division of Public Health Sciences, Seattle, Washington.
Fred Hutch Cancer Center · USAlbert Einstein College of Medicine · USBrigham and Women's Hospital · USCity Of Hope National Medical Center · USHarbor–UCLA Medical Center · USStanford University · USStony Brook University · USThe Barbara Ann Karmanos Cancer Institute · USUniversity of Iowa · US

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Christopher K Laubenthal · 2000 to 2026
$70.0M
6 · The paper itself

Abstract

Importance: In a randomized clinical trial, a low-fat eating pattern was associated with lower risk of death after breast cancer. However, the extent to which results were driven by dietary influence on survival after breast cancer diagnosis was unknown. Objective: To determine the association of a low-fat dietary pattern with breast cancer overall survival (breast cancer followed by death from any cause measured from cancer diagnosis). Design, Setting, and Participants: This is a secondary analysis of the Women's Health Initiative randomized clinical trial that was conducted at 40 US clinical centers enrolling participants from 1993 through 1998. Participants were 48 835 postmenopausal women with no previous breast cancer and dietary fat intake of greater than 32% by food frequency questionnaire. Interventions: Participants were randomized to a dietary intervention group (40%; n = 19 541) with goals to reduce fat intake to 20% of energy and increase fruit, vegetable, and grain intake or a usual-diet comparison group (60%; n = 29 294). Dietary group participants with incident breast cancers continued to participate in subsequent dietary intervention activities. Main Outcomes and Measures: Breast cancer overall survival for incident breast cancers diagnosed during the 8.5-year (median) dietary intervention, examined in post hoc analyses after 11.5 years (median) postdiagnosis follow-up. Results: Of 1764 women diagnosed with breast cancer during the dietary intervention period, mean (SD) age at screening was 62.7 (6.7) years and age at diagnosis was 67.6 (6.9) years. With 516 total deaths, breast cancer overall survival was significantly greater for women in the dietary intervention group than in the usual-diet comparison group (10-year survival of 82% and 78%, respectively; hazard ratio [HR], 0.78; 95% CI, 0.65-0.94; P = .01). In the dietary group there were fewer deaths from breast cancer (68 vs 120; HR, 0.86; 95% CI, 0.64-1.17), other cancers (36 vs 65; HR, 0.76; 95% CI, 0.50-1.17), and cardiovascular disease (27 vs 64; HR, 0.62; 95% CI, 0.39-0.99). Conclusions and Relevance: In women who received a diagnosis of breast cancer during the dietary intervention period, those in the dietary group had increased overall survival. The increase is due, in part, to better survival from several causes of death. Trial Registration: ClinicalTrials.gov Identifier: NCT00000611.

Indexed as

DietAgedBreast NeoplasmsDietary FatsDiet TherapyFemaleHumansMiddle AgedRisk FactorsSurvival AnalysisWomen's HealthDietary Fats

Identifiers

PMID29800122
PMCPMC6233778
OpenAlexW2804684386

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.